{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:18:58Z","timestamp":1792441138348,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1053\/j.gastro.2010.11.052","type":"journal-article","created":{"date-parts":[[2010,12,5]],"date-time":"2010-12-05T04:14:55Z","timestamp":1291522495000},"page":"809-817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Incidence and Risk Factors for Steatosis Progression in Adults Coinfected With HIV and Hepatitis C Virus"],"prefix":"10.1053","volume":"140","author":[{"given":"Tinsay A.","family":"Woreta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine G.","family":"Sutcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti H.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd T.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Torbenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Sulkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2010.11.052_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-138-3-200302040-00012","article-title":"Hepatitis C in the HIV-infected person","volume":"138","author":"Sulkowski","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2010.11.052_bib2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1086\/339042","article-title":"Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group","volume":"34","author":"Sherman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.gastro.2010.11.052_bib3","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1097\/QAD.0b013e3282f10de9","article-title":"Rapid fibrosis progression among HIV\/hepatitis C virus-co-infected adults","volume":"21","author":"Sulkowski","year":"2007","journal-title":"AIDS"},{"key":"10.1053\/j.gastro.2010.11.052_bib4","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/00002030-200308150-00009","article-title":"Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study)","volume":"17","author":"Rosenthal","year":"2003","journal-title":"AIDS"},{"key":"10.1053\/j.gastro.2010.11.052_bib5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/318501","article-title":"Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection","volume":"32","author":"Bica","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.gastro.2010.11.052_bib6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.aids.0000210606.63138.f5","article-title":"Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors","volume":"20","author":"Bani-Sadr","year":"2006","journal-title":"AIDS"},{"key":"10.1053\/j.gastro.2010.11.052_bib7","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/j.1365-2036.2007.03533.x","article-title":"Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype","volume":"26","author":"Cast\u00e9ra","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2010.11.052_bib8","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2006.02.009","article-title":"Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection","volume":"44","author":"Gaslightwala","year":"2006","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.11.052_bib9","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1086\/497608","article-title":"Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus","volume":"192","author":"Marks","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1053\/j.gastro.2010.11.052_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1086\/505495","article-title":"Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infections in HIV-seropositive patients","volume":"43","author":"McGovern","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.gastro.2010.11.052_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.20805","article-title":"Hepatic steatosis in HIV\/hepatitis C coinfection: prevalence and significance compared with hepatitis C monoinfection","volume":"42","author":"Monto","year":"2005","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.11.052_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/QAI.0b013e318042e1db","article-title":"Prevalence of and factors associated with hepatic steatosis in patients coinfected with hepatitis C virus and HIV","volume":"45","author":"Neau","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1053\/j.gastro.2010.11.052_bib13","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jhep.2008.01.015","article-title":"Hepatic steatosis in HIV\/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study","volume":"48","author":"Rodr\u00edguez-Torres","year":"2008","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.11.052_bib14","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.22134","article-title":"Steatohepatitis: risk factors and impact on disease severity in human immunodeficiency virus\/hepatitis C virus coinfection","volume":"47","author":"Sterling","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.11.052_bib15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/01.aids.0000163935.99401.25","article-title":"Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus","volume":"19","author":"Sulkowski","year":"2005","journal-title":"AIDS"},{"key":"10.1053\/j.gastro.2010.11.052_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0168-8278(03)00479-3","article-title":"Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States","volume":"40","author":"Hu","year":"2004","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.11.052_bib17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1053\/jhep.2002.35064","article-title":"Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol","volume":"36","author":"Monto","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.11.052_bib18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0168-8278(00)80166-X","article-title":"Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3","volume":"33","author":"Rubbia-Brandt","year":"2000","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.11.052_bib19","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1053\/j.gastro.2010.11.052_bib20","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00002030-200411050-00005","article-title":"The effects of HIV protease inhibitors atazanavir and lopinavir\/ritonavir on insulin sensitivity in HIV-seronegative healthy adults","volume":"18","author":"Noor","year":"2004","journal-title":"AIDS"},{"key":"10.1053\/j.gastro.2010.11.052_bib21","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/00002030-199814000-00004","article-title":"Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway","volume":"12","author":"Brinkman","year":"1998","journal-title":"AIDS"},{"key":"10.1053\/j.gastro.2010.11.052_bib22","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1309\/8B8BJ6AP5KGV7C1H","article-title":"Toxic effects of nucleoside reverse transcriptase inhibitors on the liver: value of electron microscopy analysis for the diagnosis of mitochondrial cytopathy","volume":"119","author":"Van Huyen","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.gastro.2010.11.052_bib23","series-title":"Guidelines for use in primary care","article-title":"AUDIT: The Alcohol Use Disorders Identification Test","author":"Babor","year":"2001"},{"key":"10.1053\/j.gastro.2010.11.052_bib24","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.11.052_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.11.052_bib26","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1053\/j.gastro.2009.06.040","article-title":"Coinfection with HIV-1 and HCV\u2014a one-two punch","volume":"137","author":"Kim","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.11.052_bib27","first-page":"1","article-title":"Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents","year":"2009"},{"key":"10.1053\/j.gastro.2010.11.052_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2036.2009.03995.x","article-title":"Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients","volume":"30","author":"Halfon","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2010.11.052_bib29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2010.11.052_bib30","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa040842","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients","volume":"351","author":"Torriani","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2010.11.052_bib31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jana.2009.02.006","article-title":"HIV infection and obesity: a review of the evidence","volume":"20","author":"Keithley","year":"2009","journal-title":"J Assoc Nurses AIDS Care"},{"key":"10.1053\/j.gastro.2010.11.052_bib32","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C","volume":"38","author":"Bedossa","year":"2003","journal-title":"Hepatology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508510017427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508510017427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T14:55:09Z","timestamp":1758034509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508510017427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0016508510017427"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2010.11.052","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Risk Factors for Steatosis Progression in Adults Coinfected With HIV and Hepatitis C Virus","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2010.11.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}